PDMR DEALING - PURCHASE OF SHARES

Summary by AI BETAClose X

On September 24, 2025, PureTech Health plc announced that several of its directors purchased ordinary shares in the market between September 22-23, 2025. Robert Lyne, Interim Chief Executive Officer, purchased 81,051 shares at GBP 1.23 per share. Sharon Barber-Lui, Interim Board Chair, acquired 65,250 shares at GBP 1.24 per share. Non-Executive Director John LaMattina bought 59,100 shares at GBP 1.25 per share, and Michele Holcomb, also a Non-Executive Director, purchased 29,239 shares at GBP 1.25 per share. In aggregate, the directors purchased 234,640 shares at a price of GBP 1.24 per share on the London Stock Exchange.

Disclaimer*

UK 100

Latest directors dealings